PATENT CLAIM ANALYSIS

Application Number: 15867240
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "454000"]

Abstract:
A cannabis plant extract based formulation to aid in stabilizing the therapeutic efficacy of cannabinoid containing treatments in patients affected with neurological diseases that comprises one or more of the following: Cannabidiol (CBD), tetrahydrocannabinol (THC), and terpenes; wherein the formulation comprises a high ratio of CBD to THC, with each of those cannabinoids in a relatively high concentration. The formulation also comprises Beta-caryophyllene that is used to further aid in neuroprotection by co-modulating CB1 and 2 receptors. Additionally, the formulation comprises the terpene humulene to assist in creating an “entourage effect” in conjunction with CBD, THC, and Beta-caryophyllene to stabilize and enhance treatment-related pharmacological actions. The formulation may also comprise Cannabichromene (CBC), Cannabigerol (CBG), and Cannabinol (CBN).

Claim (Index 1):
A formulation, comprising:\n at least 30% tetrahydrocannabinol; at least 8% cannabidiol; and at least 10% beta-caryophyllene.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 86.0
- Lexical Diversity: 1.68235
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14498555', '15452925', '15719430', '14919245', '15676407']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7349803715988515
- 35 USC 102 Novelty (BERT): 0.49601470670982
- Combined Prediction Score: 0.7110838051099484
- Mean Citation Score: 205.046664
- Max Citation Score: 215.12622
- Similarity Product: 145.6013264507818

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test